| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Camelus | 15 | 2019 | 1425 | 1.99 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 26 | 2021 | 8843 | 1.37 | Why? |
| Chiroptera | 12 | 2021 | 3530 | 0.85 | Why? |
| Coronavirus | 20 | 2020 | 18339 | 0.82 | Why? |
| Endemic Diseases | 3 | 2018 | 480 | 0.77 | Why? |
| Transfusion Reaction | 2 | 2020 | 245 | 0.73 | Why? |
| Food Services | 1 | 2020 | 156 | 0.73 | Why? |
| Animal Diseases | 3 | 2016 | 182 | 0.73 | Why? |
| Phylogeny | 18 | 2021 | 13341 | 0.69 | Why? |
| Coronavirus 229E, Human | 5 | 2021 | 1241 | 0.65 | Why? |
| Blood Safety | 1 | 2020 | 459 | 0.57 | Why? |
| Blood Donors | 4 | 2021 | 2956 | 0.55 | Why? |
| Coronaviridae | 3 | 2020 | 923 | 0.55 | Why? |
| Real-Time Polymerase Chain Reaction | 10 | 2021 | 11367 | 0.52 | Why? |
| Donor Selection | 1 | 2020 | 804 | 0.51 | Why? |
| Coronavirus Infections | 52 | 2020 | 253789 | 0.49 | Why? |
| Respiratory Tract Infections | 7 | 2019 | 6817 | 0.48 | Why? |
| Antibodies, Viral | 25 | 2021 | 51949 | 0.46 | Why? |
| Proteome | 2 | 2021 | 1812 | 0.45 | Why? |
| Genetic Variation | 4 | 2021 | 3919 | 0.44 | Why? |
| Germany | 15 | 2021 | 9196 | 0.44 | Why? |
| Hepatitis E virus | 3 | 2019 | 306 | 0.42 | Why? |
| Hepatitis E | 3 | 2019 | 319 | 0.40 | Why? |
| Biological Evolution | 1 | 2015 | 641 | 0.40 | Why? |
| Sequence Analysis, DNA | 8 | 2019 | 2830 | 0.39 | Why? |
| Caco-2 Cells | 5 | 2021 | 1236 | 0.38 | Why? |
| Genome, Viral | 15 | 2021 | 13157 | 0.38 | Why? |
| SARS Virus | 6 | 2020 | 13021 | 0.38 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.36 | Why? |
| Animals | 43 | 2021 | 78931 | 0.35 | Why? |
| Antigens, Viral | 3 | 2021 | 6298 | 0.34 | Why? |
| Base Sequence | 7 | 2020 | 3581 | 0.33 | Why? |
| RNA, Viral | 22 | 2021 | 32276 | 0.33 | Why? |
| Laboratory Proficiency Testing | 2 | 2019 | 85 | 0.33 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2020 | 13720 | 0.32 | Why? |
| Berlin | 3 | 2021 | 283 | 0.32 | Why? |
| Zoonoses | 6 | 2021 | 3034 | 0.31 | Why? |
| Sensitivity and Specificity | 16 | 2021 | 22971 | 0.31 | Why? |
| Asymptomatic Infections | 3 | 2021 | 7218 | 0.31 | Why? |
| Coronavirus OC43, Human | 4 | 2020 | 1157 | 0.31 | Why? |
| Kenya | 4 | 2018 | 887 | 0.31 | Why? |
| Molecular Diagnostic Techniques | 5 | 2020 | 4239 | 0.31 | Why? |
| Disease Outbreaks | 12 | 2021 | 27595 | 0.30 | Why? |
| Blood | 3 | 2020 | 274 | 0.30 | Why? |
| Virus Shedding | 6 | 2021 | 5834 | 0.30 | Why? |
| Serologic Tests | 3 | 2020 | 4359 | 0.28 | Why? |
| Coronavirus NL63, Human | 4 | 2020 | 669 | 0.26 | Why? |
| Cells, Cultured | 6 | 2021 | 5835 | 0.26 | Why? |
| Antibodies, Neutralizing | 13 | 2021 | 25288 | 0.25 | Why? |
| Feces | 9 | 2020 | 4235 | 0.25 | Why? |
| Clinical Laboratory Techniques | 6 | 2020 | 23402 | 0.25 | Why? |
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 3633 | 0.25 | Why? |
| Ghana | 5 | 2021 | 763 | 0.25 | Why? |
| Molecular Sequence Data | 5 | 2015 | 3198 | 0.25 | Why? |
| Humans | 100 | 2021 | 930598 | 0.25 | Why? |
| Evolution, Molecular | 6 | 2020 | 3691 | 0.24 | Why? |
| Antibody Formation | 1 | 2015 | 4038 | 0.23 | Why? |
| CD4-Positive T-Lymphocytes | 3 | 2021 | 4545 | 0.23 | Why? |
| Intraepithelial Lymphocytes | 1 | 2021 | 52 | 0.22 | Why? |
| Phylogeography | 3 | 2014 | 824 | 0.22 | Why? |
| History, 21st Century | 4 | 2016 | 1849 | 0.22 | Why? |
| Receptors, CCR1 | 1 | 2020 | 49 | 0.22 | Why? |
| Chemokine CCL4 | 1 | 2020 | 71 | 0.21 | Why? |
| Chemokine CCL3 | 1 | 2020 | 103 | 0.21 | Why? |
| Duodenum | 1 | 2021 | 179 | 0.21 | Why? |
| S-Phase Kinase-Associated Proteins | 1 | 2019 | 12 | 0.21 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.21 | Why? |
| Hepevirus | 1 | 2019 | 17 | 0.21 | Why? |
| Beclin-1 | 1 | 2019 | 38 | 0.21 | Why? |
| Sialic Acid Binding Ig-like Lectin 1 | 1 | 2021 | 156 | 0.20 | Why? |
| Saudi Arabia | 6 | 2019 | 4423 | 0.20 | Why? |
| Immunoglobulin G | 12 | 2021 | 21571 | 0.20 | Why? |
| Recombinases | 1 | 2021 | 137 | 0.20 | Why? |
| Polyendocrinopathies, Autoimmune | 1 | 2021 | 129 | 0.20 | Why? |
| DNA Primers | 2 | 2015 | 1170 | 0.20 | Why? |
| Myelopoiesis | 1 | 2020 | 116 | 0.20 | Why? |
| Neutralization Tests | 7 | 2021 | 6698 | 0.20 | Why? |
| Cell Line, Tumor | 2 | 2020 | 3608 | 0.20 | Why? |
| Arvicolinae | 1 | 2019 | 49 | 0.20 | Why? |
| Hepatitis A Virus, Human | 1 | 2018 | 12 | 0.20 | Why? |
| Synthetic Biology | 1 | 2020 | 99 | 0.20 | Why? |
| Astroviridae | 2 | 2017 | 57 | 0.19 | Why? |
| Capillary Permeability | 1 | 2021 | 277 | 0.19 | Why? |
| Virus Replication | 6 | 2021 | 14331 | 0.19 | Why? |
| Orthohepadnavirus | 1 | 2018 | 5 | 0.19 | Why? |
| Cebus | 1 | 2018 | 5 | 0.19 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2019 | 12361 | 0.19 | Why? |
| Betacoronavirus | 16 | 2020 | 204454 | 0.19 | Why? |
| Electric Impedance | 1 | 2021 | 283 | 0.18 | Why? |
| Transforming Growth Factor beta | 1 | 2021 | 363 | 0.18 | Why? |
| Intestinal Diseases | 1 | 2021 | 231 | 0.18 | Why? |
| Myositis | 1 | 2021 | 185 | 0.18 | Why? |
| Common Variable Immunodeficiency | 1 | 2020 | 195 | 0.18 | Why? |
| Pan troglodytes | 1 | 2018 | 157 | 0.18 | Why? |
| Immunity, Mucosal | 1 | 2021 | 426 | 0.17 | Why? |
| Hepatitis, Viral, Animal | 1 | 2019 | 274 | 0.17 | Why? |
| Liver Failure, Acute | 1 | 2021 | 279 | 0.17 | Why? |
| Reference Standards | 3 | 2020 | 1163 | 0.17 | Why? |
| Olfactory Mucosa | 1 | 2020 | 372 | 0.17 | Why? |
| Adult | 35 | 2021 | 244371 | 0.17 | Why? |
| Rotavirus | 1 | 2021 | 329 | 0.17 | Why? |
| Endothelium | 1 | 2021 | 460 | 0.17 | Why? |
| Bone Marrow | 1 | 2021 | 492 | 0.17 | Why? |
| Immunoglobulin A | 4 | 2021 | 3567 | 0.17 | Why? |
| Middle East | 4 | 2014 | 1418 | 0.17 | Why? |
| Lymphocyte Activation | 3 | 2021 | 2742 | 0.17 | Why? |
| Urine | 2 | 2020 | 469 | 0.16 | Why? |
| Ecology | 2 | 2018 | 140 | 0.16 | Why? |
| Picornaviridae | 1 | 2017 | 123 | 0.16 | Why? |
| Models, Genetic | 2 | 2018 | 434 | 0.16 | Why? |
| Camelids, New World | 2 | 2015 | 276 | 0.16 | Why? |
| Hepatitis A | 1 | 2018 | 140 | 0.16 | Why? |
| Genotype | 5 | 2021 | 4697 | 0.16 | Why? |
| Goats | 2 | 2014 | 217 | 0.16 | Why? |
| Cloning, Molecular | 1 | 2020 | 1036 | 0.16 | Why? |
| Female | 44 | 2021 | 380317 | 0.16 | Why? |
| Rotavirus Infections | 1 | 2021 | 355 | 0.16 | Why? |
| Spleen | 1 | 2021 | 877 | 0.16 | Why? |
| Rodentia | 1 | 2018 | 235 | 0.16 | Why? |
| Open Reading Frames | 4 | 2021 | 1898 | 0.16 | Why? |
| Farmers | 2 | 2017 | 280 | 0.16 | Why? |
| Reverse Genetics | 1 | 2020 | 439 | 0.16 | Why? |
| Male | 41 | 2021 | 367725 | 0.16 | Why? |
| Bayes Theorem | 5 | 2019 | 3237 | 0.15 | Why? |
| Serogroup | 2 | 2015 | 510 | 0.15 | Why? |
| Africa | 4 | 2020 | 2986 | 0.15 | Why? |
| Autophagy | 2 | 2021 | 960 | 0.15 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.15 | Why? |
| Enzyme-Linked Immunosorbent Assay | 5 | 2020 | 7868 | 0.15 | Why? |
| Host Specificity | 2 | 2018 | 926 | 0.15 | Why? |
| Sequence Homology, Nucleic Acid | 1 | 2016 | 368 | 0.14 | Why? |
| Young Adult | 15 | 2021 | 93724 | 0.14 | Why? |
| Middle Aged | 31 | 2021 | 270681 | 0.14 | Why? |
| Myeloid Cells | 1 | 2020 | 808 | 0.14 | Why? |
| Disease Reservoirs | 5 | 2018 | 1672 | 0.14 | Why? |
| Seroepidemiologic Studies | 7 | 2021 | 10017 | 0.14 | Why? |
| Viral Load | 9 | 2021 | 15850 | 0.14 | Why? |
| Muscle, Skeletal | 1 | 2021 | 915 | 0.14 | Why? |
| Aged | 28 | 2021 | 215776 | 0.14 | Why? |
| Livestock | 1 | 2015 | 184 | 0.14 | Why? |
| Sequence Deletion | 1 | 2018 | 674 | 0.13 | Why? |
| Virus Diseases | 3 | 2019 | 3779 | 0.13 | Why? |
| Viruses | 2 | 2019 | 2238 | 0.13 | Why? |
| Hedgehogs | 1 | 2013 | 56 | 0.13 | Why? |
| Cross Reactions | 4 | 2021 | 4374 | 0.13 | Why? |
| Laboratories | 2 | 2020 | 2858 | 0.13 | Why? |
| Fluorescent Antibody Technique | 2 | 2014 | 835 | 0.13 | Why? |
| Intestinal Mucosa | 1 | 2021 | 1046 | 0.13 | Why? |
| Population Density | 2 | 2019 | 694 | 0.13 | Why? |
| Seroconversion | 2 | 2021 | 2515 | 0.13 | Why? |
| Child, Preschool | 9 | 2021 | 36283 | 0.13 | Why? |
| Vero Cells | 6 | 2021 | 14117 | 0.13 | Why? |
| Aged, 80 and over | 16 | 2021 | 88759 | 0.12 | Why? |
| Adolescent | 13 | 2021 | 86841 | 0.12 | Why? |
| Pneumonia, Viral | 16 | 2020 | 243684 | 0.12 | Why? |
| Polymorphism, Restriction Fragment Length | 1 | 2012 | 116 | 0.12 | Why? |
| Hypertension | 4 | 2021 | 8895 | 0.12 | Why? |
| Pakistan | 2 | 2018 | 2302 | 0.12 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.12 | Why? |
| Americas | 1 | 2013 | 418 | 0.12 | Why? |
| Communicable Diseases, Imported | 1 | 2020 | 843 | 0.11 | Why? |
| Cell Line | 5 | 2020 | 12040 | 0.11 | Why? |
| Polymerase Chain Reaction | 4 | 2020 | 6740 | 0.11 | Why? |
| Reproducibility of Results | 4 | 2020 | 11304 | 0.11 | Why? |
| Breeding | 1 | 2011 | 60 | 0.11 | Why? |
| Cluster Analysis | 3 | 2017 | 3001 | 0.11 | Why? |
| Geography | 2 | 2014 | 1801 | 0.11 | Why? |
| Host-Pathogen Interactions | 4 | 2021 | 11041 | 0.11 | Why? |
| Phenotype | 2 | 2020 | 4037 | 0.11 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.11 | Why? |
| Respiratory System | 3 | 2021 | 3213 | 0.11 | Why? |
| Animals, Wild | 1 | 2018 | 1028 | 0.11 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.10 | Why? |
| Hepatitis B virus | 1 | 2018 | 882 | 0.10 | Why? |
| Endothelial Cells | 1 | 2021 | 2048 | 0.10 | Why? |
| Vaccination | 5 | 2021 | 19050 | 0.10 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.10 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.10 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.10 | Why? |
| Africa South of the Sahara | 1 | 2014 | 1335 | 0.10 | Why? |
| Diagnostic Tests, Routine | 1 | 2021 | 2643 | 0.10 | Why? |
| Myocardium | 1 | 2021 | 2323 | 0.10 | Why? |
| T-Lymphocytes | 3 | 2021 | 6670 | 0.10 | Why? |
| Long-Term Care | 1 | 2021 | 2047 | 0.09 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.09 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.09 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.09 | Why? |
| Virology | 1 | 2012 | 489 | 0.09 | Why? |
| Kinetics | 3 | 2021 | 3238 | 0.09 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.09 | Why? |
| Interferon Type I | 1 | 2021 | 2789 | 0.09 | Why? |
| Genomics | 1 | 2020 | 3118 | 0.09 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.09 | Why? |
| History, 20th Century | 1 | 2014 | 1282 | 0.09 | Why? |
| United Arab Emirates | 3 | 2015 | 704 | 0.08 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2021 | 5837 | 0.08 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.08 | Why? |
| Recombination, Genetic | 1 | 2014 | 1265 | 0.08 | Why? |
| Child | 8 | 2021 | 70012 | 0.08 | Why? |
| World Health Organization | 4 | 2021 | 4213 | 0.08 | Why? |
| Intestines | 1 | 2013 | 817 | 0.08 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.08 | Why? |
| Population Surveillance | 3 | 2021 | 4967 | 0.08 | Why? |
| Spike Glycoprotein, Coronavirus | 8 | 2021 | 37182 | 0.08 | Why? |
| Cattle | 3 | 2016 | 1336 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Europe | 6 | 2020 | 12702 | 0.08 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.08 | Why? |
| Epidemiological Monitoring | 1 | 2018 | 3493 | 0.07 | Why? |
| Autopsy | 3 | 2021 | 3495 | 0.07 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.07 | Why? |
| Primates | 2 | 2018 | 584 | 0.07 | Why? |
| Viral Envelope Proteins | 2 | 2020 | 3539 | 0.07 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2019 | 3388 | 0.07 | Why? |
| Immunization, Passive | 4 | 2021 | 10067 | 0.07 | Why? |
| Case-Control Studies | 5 | 2021 | 17671 | 0.07 | Why? |
| Computer Simulation | 1 | 2019 | 4982 | 0.07 | Why? |
| Renal Dialysis | 1 | 2021 | 4358 | 0.07 | Why? |
| Computational Biology | 1 | 2019 | 4514 | 0.07 | Why? |
| Sepsis | 1 | 2021 | 3517 | 0.06 | Why? |
| RNA Viruses | 1 | 2011 | 824 | 0.06 | Why? |
| Brain | 1 | 2020 | 5133 | 0.06 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.06 | Why? |
| Cricetinae | 2 | 2021 | 3344 | 0.06 | Why? |
| Sarcolemma | 1 | 2021 | 17 | 0.06 | Why? |
| Re-Epithelialization | 1 | 2021 | 29 | 0.06 | Why? |
| Spermine | 1 | 2021 | 41 | 0.06 | Why? |
| Nose | 2 | 2018 | 1093 | 0.06 | Why? |
| Antinematodal Agents | 1 | 2021 | 41 | 0.06 | Why? |
| Molecular Typing | 2 | 2013 | 280 | 0.06 | Why? |
| Benin | 1 | 2021 | 115 | 0.06 | Why? |
| Spermidine | 1 | 2021 | 56 | 0.06 | Why? |
| Occludin | 1 | 2021 | 53 | 0.06 | Why? |
| Rh-Hr Blood-Group System | 1 | 2021 | 55 | 0.05 | Why? |
| CD11 Antigens | 1 | 2020 | 74 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.05 | Why? |
| Chromosomes, Artificial, Yeast | 1 | 2020 | 31 | 0.05 | Why? |
| Actins | 1 | 2021 | 108 | 0.05 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.05 | Why? |
| Autophagosomes | 1 | 2021 | 154 | 0.05 | Why? |
| Nursing Staff, Hospital | 1 | 2014 | 1554 | 0.05 | Why? |
| Cadherins | 1 | 2021 | 145 | 0.05 | Why? |
| CD3 Complex | 1 | 2021 | 237 | 0.05 | Why? |
| Autophagy-Related Proteins | 1 | 2021 | 157 | 0.05 | Why? |
| Turbinates | 1 | 2021 | 205 | 0.05 | Why? |
| Niclosamide | 1 | 2021 | 153 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Single-Cell Analysis | 2 | 2020 | 2450 | 0.05 | Why? |
| Longitudinal Studies | 3 | 2021 | 9893 | 0.05 | Why? |
| Convalescence | 2 | 2021 | 2829 | 0.05 | Why? |
| Pharynx | 2 | 2020 | 1544 | 0.05 | Why? |
| Immunity | 2 | 2021 | 2651 | 0.05 | Why? |
| Coinfection | 1 | 2019 | 6820 | 0.05 | Why? |
| Cold Temperature | 1 | 2021 | 260 | 0.05 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.05 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.05 | Why? |
| Horses | 1 | 2021 | 474 | 0.05 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2020 | 239 | 0.05 | Why? |
| Hepatitis B Antigens | 1 | 2018 | 19 | 0.05 | Why? |
| Sequence Analysis, RNA | 2 | 2021 | 2290 | 0.05 | Why? |
| Panama | 1 | 2018 | 96 | 0.05 | Why? |
| Genetic Speciation | 1 | 2018 | 13 | 0.05 | Why? |
| Pandemics | 16 | 2021 | 389249 | 0.05 | Why? |
| Gene Knockdown Techniques | 1 | 2019 | 347 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2020 | 616 | 0.05 | Why? |
| Seasons | 3 | 2017 | 4071 | 0.05 | Why? |
| Travel | 2 | 2020 | 7220 | 0.05 | Why? |
| Organic Anion Transporters, Sodium-Dependent | 1 | 2018 | 26 | 0.05 | Why? |
| Age Factors | 4 | 2021 | 21039 | 0.05 | Why? |
| Histocompatibility Antigens Class II | 1 | 2021 | 383 | 0.05 | Why? |
| Hepatitis A virus | 1 | 2018 | 68 | 0.05 | Why? |
| Saccharomyces cerevisiae | 1 | 2020 | 339 | 0.04 | Why? |
| Ubiquitination | 1 | 2019 | 343 | 0.04 | Why? |
| Enteroviruses, Porcine | 1 | 2017 | 7 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2021 | 867 | 0.04 | Why? |
| Asia | 2 | 2017 | 2399 | 0.04 | Why? |
| CHO Cells | 1 | 2020 | 831 | 0.04 | Why? |
| Sequence Analysis | 1 | 2020 | 496 | 0.04 | Why? |
| HLA-DR Antigens | 1 | 2020 | 563 | 0.04 | Why? |
| Plasma Cells | 1 | 2021 | 464 | 0.04 | Why? |
| Cross Infection | 2 | 2017 | 8675 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2021 | 1027 | 0.04 | Why? |
| Cricetulus | 1 | 2020 | 936 | 0.04 | Why? |
| Symporters | 1 | 2018 | 80 | 0.04 | Why? |
| Shock, Septic | 2 | 2021 | 1313 | 0.04 | Why? |
| Occupational Exposure | 1 | 2016 | 4742 | 0.04 | Why? |
| Probability | 1 | 2021 | 923 | 0.04 | Why? |
| Biological Factors | 1 | 2020 | 276 | 0.04 | Why? |
| Amino Acid Sequence | 2 | 2019 | 6049 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2021 | 813 | 0.04 | Why? |
| Metabolome | 1 | 2021 | 624 | 0.04 | Why? |
| Histocompatibility Antigens Class I | 1 | 2021 | 624 | 0.04 | Why? |
| Microvessels | 1 | 2021 | 490 | 0.04 | Why? |
| Mammals | 1 | 2018 | 315 | 0.04 | Why? |
| Oman | 1 | 2017 | 345 | 0.04 | Why? |
| HEK293 Cells | 2 | 2020 | 8394 | 0.04 | Why? |
| Forests | 1 | 2017 | 132 | 0.04 | Why? |
| Monkey Diseases | 1 | 2018 | 190 | 0.04 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.04 | Why? |
| Respiratory Syncytial Viruses | 1 | 2020 | 612 | 0.04 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.04 | Why? |
| European Union | 1 | 2020 | 565 | 0.04 | Why? |
| Sequence Homology | 1 | 2017 | 448 | 0.04 | Why? |
| Mutation, Missense | 1 | 2021 | 863 | 0.04 | Why? |
| Proteolysis | 1 | 2019 | 751 | 0.04 | Why? |
| False Positive Reactions | 1 | 2021 | 1338 | 0.04 | Why? |
| Transcription Factors | 1 | 2021 | 784 | 0.04 | Why? |
| Antigens, CD | 1 | 2021 | 984 | 0.04 | Why? |
| Interleukins | 1 | 2021 | 762 | 0.04 | Why? |
| Africa, Eastern | 1 | 2014 | 90 | 0.04 | Why? |
| Abattoirs | 1 | 2015 | 94 | 0.04 | Why? |
| Central Nervous System | 1 | 2020 | 701 | 0.04 | Why? |
| Overweight | 1 | 2021 | 916 | 0.04 | Why? |
| Prevalence | 4 | 2019 | 25773 | 0.03 | Why? |
| Organoids | 1 | 2021 | 840 | 0.03 | Why? |
| Intestine, Small | 1 | 2017 | 336 | 0.03 | Why? |
| Metagenomics | 1 | 2021 | 823 | 0.03 | Why? |
| Animal Husbandry | 1 | 2015 | 162 | 0.03 | Why? |
| Poverty Areas | 1 | 2019 | 556 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2020 | 1444 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2021 | 1706 | 0.03 | Why? |
| Lung | 5 | 2021 | 31049 | 0.03 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2020 | 3607 | 0.03 | Why? |
| Leukocytes | 1 | 2021 | 1046 | 0.03 | Why? |
| False Negative Reactions | 1 | 2021 | 1785 | 0.03 | Why? |
| Myocardial Ischemia | 1 | 2021 | 781 | 0.03 | Why? |
| Cattle Diseases | 1 | 2016 | 294 | 0.03 | Why? |
| Cell Proliferation | 1 | 2021 | 1973 | 0.03 | Why? |
| Rhinovirus | 1 | 2019 | 979 | 0.03 | Why? |
| Clinical Laboratory Services | 1 | 2020 | 781 | 0.03 | Why? |
| Hot Temperature | 1 | 2021 | 1299 | 0.03 | Why? |
| Interferon-alpha | 1 | 2021 | 1442 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2020 | 2689 | 0.03 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.03 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.03 | Why? |
| Ecosystem | 1 | 2018 | 776 | 0.03 | Why? |
| Thailand | 1 | 2017 | 1155 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2021 | 1609 | 0.03 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2019 | 846 | 0.03 | Why? |
| Sentinel Surveillance | 1 | 2020 | 1093 | 0.03 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2020 | 1887 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.03 | Why? |
| Intersectoral Collaboration | 1 | 2019 | 1065 | 0.03 | Why? |
| Sheep | 1 | 2013 | 420 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Virus Cultivation | 1 | 2015 | 579 | 0.03 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.03 | Why? |
| Sputum | 1 | 2020 | 1720 | 0.03 | Why? |
| Feasibility Studies | 1 | 2021 | 3467 | 0.03 | Why? |
| Disease Notification | 1 | 2017 | 639 | 0.03 | Why? |
| Tissue Donors | 1 | 2021 | 1679 | 0.03 | Why? |
| Brazil | 2 | 2019 | 12582 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.03 | Why? |
| Smell | 1 | 2020 | 1851 | 0.03 | Why? |
| Orthomyxoviridae | 1 | 2019 | 1168 | 0.03 | Why? |
| Apoptosis | 1 | 2021 | 2335 | 0.03 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.03 | Why? |
| Interviews as Topic | 1 | 2020 | 1952 | 0.03 | Why? |
| Sequence Homology, Amino Acid | 1 | 2013 | 945 | 0.03 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2017 | 1061 | 0.03 | Why? |
| Virus Internalization | 2 | 2020 | 7921 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.03 | Why? |
| Multiple Organ Failure | 1 | 2021 | 1724 | 0.03 | Why? |
| Viral Matrix Proteins | 1 | 2018 | 1243 | 0.03 | Why? |
| Poland | 1 | 2018 | 2368 | 0.03 | Why? |
| Liver Cirrhosis | 1 | 2021 | 1810 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2020 | 5542 | 0.02 | Why? |
| Hepatitis B | 1 | 2018 | 888 | 0.02 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2021 | 9659 | 0.02 | Why? |
| Mice | 2 | 2020 | 21357 | 0.02 | Why? |
| Occupations | 1 | 2015 | 733 | 0.02 | Why? |
| Macrophages | 1 | 2021 | 2784 | 0.02 | Why? |
| Proteomics | 1 | 2020 | 2481 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.02 | Why? |
| Cross-Sectional Studies | 4 | 2018 | 53120 | 0.02 | Why? |
| Syndrome | 1 | 2014 | 1310 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.02 | Why? |
| Diarrhea | 1 | 2021 | 2743 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2020 | 3347 | 0.02 | Why? |
| Infection Control | 1 | 2017 | 23131 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2020 | 4020 | 0.02 | Why? |
| Latin America | 1 | 2013 | 1721 | 0.02 | Why? |
| Binding Sites | 1 | 2020 | 6201 | 0.02 | Why? |
| Delayed Diagnosis | 1 | 2017 | 1529 | 0.02 | Why? |
| Population Dynamics | 1 | 2011 | 378 | 0.02 | Why? |
| Zika Virus | 1 | 2020 | 1924 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2020 | 4155 | 0.02 | Why? |
| Genes, Viral | 1 | 2013 | 1428 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| China | 3 | 2020 | 50654 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| International Cooperation | 1 | 2019 | 3436 | 0.02 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.02 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.02 | Why? |
| Adenoviridae | 1 | 2011 | 1151 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
| Protein Binding | 1 | 2020 | 11430 | 0.02 | Why? |
| Fever | 1 | 2021 | 7795 | 0.02 | Why? |
| Family Characteristics | 1 | 2014 | 2551 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Fatal Outcome | 1 | 2013 | 3438 | 0.02 | Why? |
| South Africa | 1 | 2013 | 3326 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2021 | 8248 | 0.02 | Why? |
| Republic of Korea | 1 | 2016 | 5858 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.01 | Why? |
| Internationality | 1 | 2015 | 3297 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2021 | 6153 | 0.01 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Anti-Infective Agents | 1 | 2013 | 1766 | 0.01 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Receptors, Virus | 1 | 2018 | 5659 | 0.01 | Why? |
| DNA, Viral | 1 | 2011 | 2521 | 0.01 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2014 | 9706 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |